HC
ADMS

Henshaw Capital’s Adamas Pharmaceuticals ADMS Stock Holding History

Henshaw Capital’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-11,272
Closed -$32.6K – 322
2020
Q1 		$32.6K Buy
+11,272
New +$50.5K ﹤0.01% 279
2019
Q4 		– Sell
-10,443
Closed -$53.4K – 313
2019
Q3 		$53.4K Hold
10,443
– – ﹤0.01% 284
2019
Q2 		$64.7K Hold
10,443
– – 0.01% 292
2019
Q1 		$74.3K Hold
10,443
– – 0.01% 282
2018
Q4 		$89.2K Buy
+10,443
New +$136K 0.01% 268

Other funds holding ADMS

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return